enVVeno Medical (NVNO) Competitors

$10.54 -0.15 (-1.36%)

Closing price 03:59 PM Eastern

Extended Trading

$10.44 -0.10 (-0.95%)

As of 04:04 PM Eastern

NVNO vs. PETV, MLSS, FEMY, ICCM, and POAI

Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include PetVivo (PETV), Milestone Scientific (MLSS), Femasys (FEMY), IceCure Medical (ICCM), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry.

How does enVVeno Medical compare to PetVivo?

PetVivo (NASDAQ:PETV) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings, dividends and media sentiment.

: 24.5% of PetVivo shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 10.8% of PetVivo shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: PetVivo has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500.
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PetVivo
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50
: enVVeno Medical has a net margin of 0.00% compared to PetVivo's net margin of -902.82%. enVVeno Medical's return on equity of -60.88% beat PetVivo's return on equity.
Company Net Margins Return on Equity Return on Assets
PetVivo -902.82% -4,813.07% -281.78%
enVVeno Medical N/A -60.88% -56.01%
: PetVivo has higher revenue and earnings than enVVeno Medical. PetVivo is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
PetVivo $1.05M 26.73 -$10.95M -$0.38 N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: In the previous week, PetVivo had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for PetVivo and 0 mentions for enVVeno Medical. PetVivo's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
PetVivo Neutral
enVVeno Medical Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PetVivo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Company	Net Margins	Return on Equity	Return on Assets
PetVivo	-902.82%	-4,813.07%	-281.78%
enVVeno Medical	N/A	-60.88%	-56.01%

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PetVivo	$1.05M	26.73	-$10.95M	-$0.38	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Overall Sentiment
PetVivo	Neutral
enVVeno Medical	Neutral

Summary

enVVeno Medical beats PetVivo on 7 of the 12 factors compared between the two stocks.

How does enVVeno Medical compare to Milestone Scientific?

Milestone Scientific (NYSE:MLSS) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

: Milestone Scientific has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
: Milestone Scientific has higher revenue and earnings than enVVeno Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Milestone Scientific $8.97M 3.53 -$6.93M -$0.06 N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: enVVeno Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat enVVeno Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Milestone Scientific -52.01% -60.26% -40.23%
enVVeno Medical N/A -60.88% -56.01%
: Milestone Scientific presently has a consensus target price of $1.00, indicating a potential upside of 153.81%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Milestone Scientific is more favorable than enVVeno Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)

1 Buy rating(s)

0 Strong Buy rating(s)
3.00
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50
: In the previous week, Milestone Scientific's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
Milestone Scientific Neutral
enVVeno Medical Neutral
: 5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 12.5% of Milestone Scientific shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.97M	3.53	-$6.93M	-$0.06	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
enVVeno Medical	N/A	-60.88%	-56.01%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Company	Overall Sentiment
Milestone Scientific	Neutral
enVVeno Medical	Neutral

Summary

Milestone Scientific beats enVVeno Medical on 8 of the 13 factors compared between the two stocks.

How does enVVeno Medical compare to Femasys?

Femasys (NASDAQ:FEMY) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

: Femasys currently has a consensus target price of $5.50, indicating a potential upside of 1,261.39%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than enVVeno Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Femasys
1 Sell rating(s)
0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.60
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50
: 65.3% of Femasys shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 7.6% of Femasys shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
: Femasys has a beta of -2.26, meaning that its stock price is 326% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
: Femasys has higher revenue and earnings than enVVeno Medical. Femasys is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Femasys $2.29M 10.65 -$18.63M -$0.50 N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: enVVeno Medical has a net margin of 0.00% compared to Femasys' net margin of -812.74%. enVVeno Medical's return on equity of -60.88% beat Femasys' return on equity.
Company Net Margins Return on Equity Return on Assets
Femasys -812.74% -534.94% -116.29%
enVVeno Medical N/A -60.88% -56.01%
: In the previous week, Femasys had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 1 mentions for Femasys and 0 mentions for enVVeno Medical. Femasys' average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
Femasys Neutral
enVVeno Medical Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Femasys	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Femasys	$2.29M	10.65	-$18.63M	-$0.50	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Net Margins	Return on Equity	Return on Assets
Femasys	-812.74%	-534.94%	-116.29%
enVVeno Medical	N/A	-60.88%	-56.01%

Company	Overall Sentiment
Femasys	Neutral
enVVeno Medical	Neutral

Summary

Femasys beats enVVeno Medical on 8 of the 14 factors compared between the two stocks.

How does enVVeno Medical compare to IceCure Medical?

IceCure Medical (NASDAQ:ICCM) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

: IceCure Medical has higher revenue and earnings than enVVeno Medical. IceCure Medical is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
IceCure Medical $3.38M 6.72 -$15.06M -$0.24 N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: 0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
: IceCure Medical has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500.
: enVVeno Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -445.61%. enVVeno Medical's return on equity of -60.88% beat IceCure Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
IceCure Medical -445.61% -221.04% -118.89%
enVVeno Medical N/A -60.88% -56.01%
: In the previous week, IceCure Medical had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 1 mentions for IceCure Medical and 0 mentions for enVVeno Medical. IceCure Medical's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
IceCure Medical Neutral
enVVeno Medical Neutral
: IceCure Medical currently has a consensus target price of $2.64, indicating a potential upside of 841.07%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than enVVeno Medical.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	6.72	-$15.06M	-$0.24	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-445.61%	-221.04%	-118.89%
enVVeno Medical	N/A	-60.88%	-56.01%

Company	Overall Sentiment
IceCure Medical	Neutral
enVVeno Medical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

IceCure Medical and enVVeno Medical tied by winning 7 of the 14 factors compared between the two stocks.

How does enVVeno Medical compare to Predictive Oncology?

Predictive Oncology (NASDAQ:POAI) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

: Predictive Oncology has higher revenue and earnings than enVVeno Medical. Predictive Oncology is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Predictive Oncology $1.66M 10.60 -$12.66M -$13.50 N/A
enVVeno Medical N/A N/A -$19.47M -$37.89 N/A
: 9.0% of Predictive Oncology shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 1.2% of Predictive Oncology shares are held by insiders. Comparatively, 15.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
: Predictive Oncology has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500.
: enVVeno Medical has a net margin of 0.00% compared to Predictive Oncology's net margin of -5,065.23%. enVVeno Medical's return on equity of -60.88% beat Predictive Oncology's return on equity.
Company Net Margins Return on Equity Return on Assets
Predictive Oncology -5,065.23% -732.73% -235.55%
enVVeno Medical N/A -60.88% -56.01%
: In the previous week, Predictive Oncology had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 1 mentions for Predictive Oncology and 0 mentions for enVVeno Medical. Predictive Oncology's average media sentiment score of 0.00 equaled enVVeno Medical'saverage media sentiment score.
Company Overall Sentiment
Predictive Oncology Neutral
enVVeno Medical Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Predictive Oncology
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
enVVeno Medical
1 Sell rating(s)

1 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.50

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Predictive Oncology	$1.66M	10.60	-$12.66M	-$13.50	N/A
enVVeno Medical	N/A	N/A	-$19.47M	-$37.89	N/A

Company	Net Margins	Return on Equity	Return on Assets
Predictive Oncology	-5,065.23%	-732.73%	-235.55%
enVVeno Medical	N/A	-60.88%	-56.01%

Company	Overall Sentiment
Predictive Oncology	Neutral
enVVeno Medical	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
enVVeno Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Summary

enVVeno Medical beats Predictive Oncology on 7 of the 12 factors compared between the two stocks.

Get enVVeno Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVNO vs. The Competition

Export

Metric	enVVeno Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$6.91M	$7.14B	$6.25B	$11.87B
Dividend Yield	N/A	1.75%	2.73%	5.21%
P/E Ratio	-0.28	29.58	29.03	28.47
Price / Sales	N/A	55.73	476.10	60.92
Price / Cash	N/A	24.91	27.62	36.52
Price / Book	0.25	7.18	9.67	6.67
Net Income	-$19.47M	$158.34M	$3.55B	$332.53M
7 Day Performance	-14.77%	2.73%	1.75%	2.03%
1 Month Performance	0.05%	5.05%	5.66%	9.23%
1 Year Performance	-91.57%	-3.14%	34.42%	39.62%

enVVeno Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVNO enVVeno Medical	0.3544 of 5 stars	$10.54 -1.4%	N/A	N/A	$6.91M	N/A	N/A	30
PETV PetVivo	N/A	$0.78 -2.3%	N/A	N/A	$27.98M	$1.05M	N/A	20	Gap Down
MLSS Milestone Scientific	1.2228 of 5 stars	$0.31 -4.9%	$1.00 +222.6%	N/A	$24.94M	$8.97M	N/A	30
FEMY Femasys	1.8042 of 5 stars	$0.37 0.0%	$5.50 +1,374.9%	N/A	$22.52M	$2.29M	N/A	30	News Coverage Upcoming Earnings Gap Up
ICCM IceCure Medical	2.1551 of 5 stars	$0.27 -1.3%	$2.64 +875.6%	N/A	$21.93M	$3.38M	N/A	60	News Coverage Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NVNO) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

enVVeno Medical (NVNO) Competitors

NVNO vs. PETV, MLSS, FEMY, ICCM, and POAI

How does enVVeno Medical compare to PetVivo?

Summary

How does enVVeno Medical compare to Milestone Scientific?

Summary

How does enVVeno Medical compare to Femasys?

Summary

How does enVVeno Medical compare to IceCure Medical?

Summary

How does enVVeno Medical compare to Predictive Oncology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

enVVeno Medical (NVNO) Competitors

NVNO vs. PETV, MLSS, FEMY, ICCM, and POAI

How does enVVeno Medical compare to PetVivo?

Summary

How does enVVeno Medical compare to Milestone Scientific?

Summary

How does enVVeno Medical compare to Femasys?

Summary

How does enVVeno Medical compare to IceCure Medical?

Summary

How does enVVeno Medical compare to Predictive Oncology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVNO vs. The Competition

enVVeno Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools